Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study
2011 ◽
Vol 28
(6)
◽
pp. 715-723
◽
Keyword(s):
2009 ◽
Vol 25
(11)
◽
pp. 2601-2608
◽
Keyword(s):
Keyword(s):
2005 ◽
Vol 27
(9)
◽
pp. 1432-1443
◽
Keyword(s):
2013 ◽
Vol 15
(6)
◽
pp. 513-519
◽
Keyword(s):
2020 ◽
Vol 17
(20)
◽
pp. 7587
Keyword(s):
2015 ◽
Vol 16
(11)
◽
pp. 1577-1591
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 10
(11)
◽
pp. 1467